(Press-News.org) PHILADELPHIA, Aug. 22, 2012 — Like recruiters pitching military service to a throng of people, scientists are developing drugs to recruit disease-fighting proteins present naturally in everyone's blood in medicine's war on infections, cancer and a range of other diseases. They reported on the latest advances in this new approach here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
David Spiegel, M.D., Ph.D., who heads one of the major research teams developing "antibody-recruiting molecules" (or ARMs), said that the approach is a response to the old and seemingly impossible dream of identifying "magic bullets" for wide-ranging diseases. Antibodies are components of the immune defense system that latch onto microbes and other foreign material in the body and mark them for destruction.
"Antibodies have been wonderful drugs for autoimmune diseases and cancer," Spiegel explained. "But, like other protein-based drugs, they cannot be given in a pill, and must be injected. They can also cause life-threatening allergic or immune reactions. We are developing a work-around ― antibody-recruiting medicines that can be taken orally and induce a patient's own antibodies to fight disease. They would be less expensive and easier to make. We hope it's the starting point toward entirely new approaches for treating a wide range of diseases."
Everyone has numerous antibodies circulating in the blood, each programmed by the immune system to latch onto and mark for destruction specific bacteria, viruses, allergens (like plant pollen) and other material ― termed antigens ― that the body recognizes as foreign. The body makes these antibodies as people are exposed to microbes and allergens in the environment.
However, researchers don't know why people have antibodies against some structures, like the 2,4-dinitrophenyl (DNP) epitope, which is similar to ingredients found in certain pesticides and agricultural chemicals. It could be due to environmental exposures, but researchers also think the body could have made these antibodies when exposed to some other substance that resembles DNP.
Antibodies against DNP are what Spiegel's team at Yale University is using in one strategy to make the immune system target various cancers and HIV, the virus that causes AIDS.
Most of the medications in use today, from aspirin to cancer chemotherapy drugs, fall into that small-molecule category, just like ARMs.
"These ARMs don't kill HIV directly," Spiegel explained. "Instead, they just trick the body into targeting HIV for destruction by its normal immune mechanisms."
ARMs for cancer work well in laboratory mice, which are stand-ins for humans in these types of experiments, and such tests for anti-HIV ARMs are currently ongoing. Spiegel said that ARMs could also be designed to treat other conditions, such as autoimmune diseases like rheumatoid arthritis.
The team is using another approach against Staph infections. It involves tricking bacteria into the equivalent of painting a "bull's eye" on themselves, in effect inviting attack by the immune system. It represents the first time that scientists have been able to actually put small molecules into the surface of Staphylococcus aureus, which is becoming more and more resistant to traditional antibiotics. Spiegel said that this method also might work on other types of bacteria, such as Streptococcus microbes that cause pneumonia and strep throat.
###
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society.
Abstract
Synthetic Immunology, the development of synthetic systems capable of modulating and/or manipulating immunological functions, represents an emerging field of research with manifold possibilities. Our laboratory's work in this area has included efforts to create low molecular-weight synthetic species, called antibody-recruiting molecules (ARMs), which are capable of enhancing antibody binding to disease-relevant cells or viruses, thus leading to immune-mediated clearance of these targets. This presentation will describe the development of ARM technologies with a particular emphasis on applications related to infectious agents, including HIV and Staph. aureus. In addition to exploring the potential therapeutic utility of ARMs and related structures, these research efforts have led to a number of unexpected scientific discoveries. Hopefully this presentation will provide insight into the many exciting research possibilities at the interface of organic chemistry, immunobiology, and infectious disease.
Toward medicines that recruit the body's natural disease-fighting proteins
2012-08-23
ELSE PRESS RELEASES FROM THIS DATE:
Archived Guthrie cards find a new purpose
2012-08-23
August 23, 2012 – Over the last 50 years, the spotting of newborn's blood onto filter paper for disease screening, called Guthrie cards, has become so routine that since 2000, more than 90% of newborns in the United States have had Guthrie cards created. In a study published online in Genome Research, researchers have shown that epigenetic information stored on archived Guthrie cards provides a retrospective view of the epigenome at birth, a powerful new application for the card that could help understand disease and predict future health.
DNA methylation, an epigenetic ...
NIH researchers find possible cause of immune deficiency cases in Asia
2012-08-23
A clinical study led by National Institutes of Health investigators has identified an antibody that compromises the immune systems of HIV-negative people, making them susceptible to infections with opportunistic microbes such as nontuberculous mycobacteria (NTM). In this study conducted at hospitals in Thailand and Taiwan, the researchers found that the majority of study participants with opportunistic infections made an antibody against interferon-gamma (IFN-gamma), a cell-signaling molecule thought to play a major role in clearing harmful infections. The study findings ...
Self-awareness in humans is more complex, diffuse than previously thought
2012-08-23
Ancient Greek philosophers considered the ability to "know thyself" as the pinnacle of humanity. Now, thousands of years later, neuroscientists are trying to decipher precisely how the human brain constructs our sense of self.
Self-awareness is defined as being aware of oneself, including one's traits, feelings, and behaviors. Neuroscientists have believed that three brain regions are critical for self-awareness: the insular cortex, the anterior cingulate cortex, and the medial prefrontal cortex. However, a research team led by the University of Iowa has challenged this ...
Experts say ethical dilemmas contribute to 'critical weaknesses' in FDA postmarket oversight
2012-08-23
Ethical challenges are central to persistent "critical weaknesses" in the national system for ensuring drug safety, according to a commentary by former Institute of Medicine (IOM) committee members published today in the New England Journal of Medicine.
With a caution against "reactive policymaking," committee co-chairs Ruth Faden, Ph.D., M.P.H., and Steven Goodman, M.D., M.H.S., Ph.D., with fellow committee member Michelle Mello, J.D., Ph.D., revisit the controversy over the antidiabetic drug Avandia that led to the formation of their IOM committee on monitoring drug ...
NIH uses genome sequencing to help quell bacterial outbreak in Clinical Center
2012-08-23
For six months last year, a deadly outbreak of antibiotic-resistant bacteria kept infection-control specialists at the National Institutes of Health's (NIH) Clinical Center in a state of high alert. A New York City patient carrying a multi-drug resistant strain of Klebsiella pneumoniae, a microbe frequently associated with hospital-borne infections, introduced the dangerous bacteria into the 243-bed research hospital while participating in a clinical study in the summer of 2011.
Despite enhanced infection-control practices, including patient isolation, the K. pneumoniae ...
Study suggests early exposure to antibiotics may impact development, obesity
2012-08-23
NEW YORK, August 22, 2012 – Researchers at NYU School of Medicine have made a novel discovery that could have widespread clinical implications, potentially affecting everything from nutrient metabolism to obesity in children.
Since the 1950's, low dose antibiotics have been widely used as growth promoters in the agricultural industry. For decades, livestock growers have employed subtherapeutic antibiotic therapy (STAT), not to fight infection or disease, but to increase weight gain in cattle, swine, sheep, chickens and turkey, among other farm animals.
First author ...
Sky-high methane mystery closer to being solved, UCI researchers say
2012-08-23
Irvine, Calif. – Increased capture of natural gas from oil fields probably accounts for up to 70 percent of the dramatic leveling off seen in atmospheric methane at the end of the 20th century, according to new UC Irvine research being published Thursday, Aug. 23, in the journal Nature.
"We can now say with confidence that, based on our data, the trend is largely a result of changes in fossil fuel use," said chemistry professor Donald Blake, senior author on the paper.
Methane has 20 times the global warming potential of carbon dioxide, although CO2 is filling the ...
Low-dose sedative alleviates autistic-like behavior in mice with Dravet syndrome mutation
2012-08-23
A low dose of the sedative clonazepam alleviated autistic-like behavior in mice with a mutation that causes Dravet syndrome in humans, University of Washington researchers have shown.
Dravet syndrome is an infant seizure disorder accompanied by developmental delays and behavioral symptoms that include autistic features. It usually originates spontaneously from a gene mutation in an affected child not found in either parent.
Studies of mice with a similar gene mutation are revealing the overly excited brain circuits behind the autistic traits and cognitive impairments ...
Scientists reveal how river blindness worm thrives
2012-08-23
Scientists at the University of Liverpool have found that the worm which causes River Blindness survives by using a bacterium to provide energy, as well as help 'trick' the body's immune system into thinking it is fighting a different kind of infection.
River Blindness affects 37 million people, mainly in sub-Saharan Africa, causing intense itching of the skin, visual impairment and in severe cases, irreversible blindness. It is caused by a parasitic worm that is transmitted by blood-feeding blackflies, which breed in fast-flowing rivers.
The team at Liverpool investigated ...
New climate history adds to understanding of recent Antarctic Peninsula warming
2012-08-23
Results published this week by a team of polar scientists from Britain, Australia and France adds a new dimension to our understanding of Antarctic Peninsula climate change and the likely causes of the break-up of its ice shelves.
The first comprehensive reconstruction of a 15,000 year climate history from an ice core collected from James Ross Island in the Antarctic Peninsula region is reported this week in the journal Nature. The scientists reveal that the rapid warming of this region over the last 100 -years has been unprecedented and came on top of a slower natural ...